Concerns Australia will miss out on vital COVID-19 treatment as US 'hoards' remdesivir supply

The Trump administration has moved to secure almost all stocks of the drug remdesivir until October, leaving public health experts fearing many other countries, including Australia, will miss out on accessing the treatment

A vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the US. Source: Gilead Sciences

There are fears Australia is amongst many other countries barred from accessing new Coronavirus treatments after the United States moved to secure near-exclusive access to the antiviral drug remdesivir for the next three months.

Read the full article in English here.